Paul Schaffer

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York.

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada.

The Vancouver Prostate Centre provides prostate cancer research, treatment, and education services. Its comprehensive, in-house research program ranges from molecular biology to functional genomics, and encompasses active clinical trials, socio-behavioral studies and research into complementary and alternative medicine. The company was founded in 1998 and is headquartered in Vancouver, Canada.

Glibro Holding SA is a financial holding Luxembourger company founded in 1994. The private company is based in Luxembourg, LU. The company operates as a financial holding company. and has subsidiaries in United Kingdom and Ireland.

Part of Glibro Holding SA, Glibro Investments Ltd. is an Irish company that provides financial intermediation services.

Glibro Design Ltd., part of Glibro Holding SA, is an Irish company. The firm manufactures outwear.

Eirn Consultancy Ltd. is an Irish private company that provides business and management consulting services.

Knowledge First Financial, Inc. operates as an investment fund manager, administrator and distributor. It offers Registered Education Savings Plans (RESP) and financial services. The company was founded in 1965 and is headquartered in Mississauga, Canada.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

V-Wave Ltd. engages in the development of implantable medical device for treating chronic heart failure. It offers V-Wave Shunt, which is a biocompatible inter-atrial unidirectional implant. The company was founded by Gad Keren and Yaacov Nitzan in 2009 and is headquartered in Caesarea, Israel.

Phemi SystemsCorp., operates as a big data warehouse company. It serves to healthcare institutions. The firm’s products include PHEMI central and PHEMI clinical. The company was founded by Alan Rabinowitz, Paul Terry, Adam Lorant, and John M. Seminerio in 2013 and is headquartered in Vancouver, Canada.

Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.

PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada.

Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada.

Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom.

Microdermics, Inc. designs, builds, tests, and manufactures proprietary hollow metal microneedles that will eliminate the need for hypodermic needles for many therapeutics and traditional intramuscular vaccinations. It focuses on commercializing a novel hollow microneedle delivery platform targeting the multi-billion biopharmaceutical market. The company was founded by Sahan Ranamukharachchi, Iman Mansoor, Urs O. Häfeli, and Boris Stoeber in June 2014 and is headquartered in Vancouver, Canada.

Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada.

Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada.

Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada.

Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada.

TRIUMF Innovations, Inc. is the business interface and commercialization arm of TRIUMF, Canada's particle accelerator center. The private company is based in Vancouver, Canada. The Canadian company connects TRIUMF to the private sector through industry partnerships, licensing, and company creation. Kathryn Hayashi has been the CEO of the company since 2017.

Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada.

Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation.

adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.

Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.

Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes.

Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.